Your browser doesn't support javascript.
loading
Remibrutinib inhibits hives effector cells stimulated by serum from chronic urticaria patients independently of FcεR1 expression level and omalizumab clinical response.
Gimeno, Ramón; Ribas-Llauradó, Clara; Pesque, David; Andrades, Evelyn; Cenni, Bruno; Ambros, Barbara; Pujol, Ramon; Giménez-Arnau, Ana M.
Afiliação
  • Gimeno R; Laboratory of Immunology, Department of Pathology, Hospital del Mar, Barcelona, Spain.
  • Ribas-Llauradó C; Department Immnology, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
  • Pesque D; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
  • Andrades E; Department Immnology, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
  • Cenni B; Department of Dermatology, Hospital del Mar, IMIM, Universitat Pompeu Fabra, Barcelona, Spain.
  • Ambros B; Department Immnology, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
  • Pujol R; Department of Dermatology, Hospital del Mar, IMIM, Universitat Pompeu Fabra, Barcelona, Spain.
  • Giménez-Arnau AM; Department of Research, BC Novartis Institutes for BioMedical Research, Novartis, Basel, Switzerland.
Clin Transl Allergy ; 13(3): e12227, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36973953
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Transl Allergy Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Transl Allergy Ano de publicação: 2023 Tipo de documento: Article